News

Health2Sync Raises US$20M in Series C to Fuel Growth and Taiwan IPO

Alzheimer's Drug Discovery Foundation ’s DIAGNOSTICS ACCELERATOR (DXA) Invests $1.4M in ViewMind’s Brain Health Assessment technology, ViewMind Atlas™

reach52’s Market‑Driven Approach Highlighted in Global Discussion on Financing NCD Treatment

reach52 works with suppliers to bring medicines and services to underserved areas

Endiatx robotic capsule for endoscopy launched at AIG Hospitals

VitruvianMD won Innovation in Health and Wellness prize at the Entrepreneurship World Cup